{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "5",
          "submission_status": "AP",
          "submission_status_date": "20160601",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "19674",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/205692Orig1s005ltr.pdf",
              "date": "20200323",
              "type": "Letter"
            },
            {
              "id": "32704",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205692s005lbl.pdf",
              "date": "20200323",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "24",
          "submission_status": "AP",
          "submission_status_date": "20191115",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "60875",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/205692Orig1021, s024, s025ltr.pdf",
              "date": "20200323",
              "type": "Letter"
            },
            {
              "id": "60892",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205692s021s024s025lbl.pdf",
              "date": "20200323",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20160617",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "10491",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=faq.page#nda_bla",
              "date": "20200323",
              "type": "Other"
            },
            {
              "id": "19673",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=faq.page#nda_bla",
              "date": "20200323",
              "type": "Other"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20151216",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 5",
          "submission_class_code_description": "Type 5 - New Formulation or New Manufacturer",
          "application_docs": [
            {
              "id": "43499",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/205692Orig1s000TOC.html",
              "date": "20200323",
              "type": "Review"
            },
            {
              "id": "44930",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/205692Orig1s000TAltr.pdf",
              "date": "20200323",
              "type": "Letter"
            },
            {
              "id": "10490",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/205692Orig1s000ltr.pdf",
              "date": "20200323",
              "type": "Letter"
            },
            {
              "id": "19672",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205692lbl.pdf",
              "date": "20200323",
              "type": "Label"
            },
            {
              "id": "32702",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/205692Orig1s000TOC.html",
              "date": "20200323",
              "type": "Review"
            },
            {
              "id": "32703",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/205692Orig1s000SumR.pdf",
              "date": "20200323",
              "type": "Summary Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "19",
          "submission_status": "AP",
          "submission_status_date": "20180905",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "55388",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/205692Orig1s019ltr.pdf",
              "date": "20200323",
              "type": "Letter"
            },
            {
              "id": "55410",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205692s019lbl.pdf",
              "date": "20200323",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "33",
          "submission_status": "AP",
          "submission_status_date": "20210720",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "68149",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/205692Orig1s033ltr.pdf",
              "date": "20210722",
              "type": "Letter"
            },
            {
              "id": "68168",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205692s033lbl.pdf",
              "date": "20210723",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "25",
          "submission_status": "AP",
          "submission_status_date": "20191115",
          "review_priority": "901 REQUIRED",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "60874",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205692s021s024s025lbl.pdf",
              "date": "20200323",
              "type": "Label"
            },
            {
              "id": "60893",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/205692Orig1021, s024, s025ltr.pdf",
              "date": "20200323",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20160617",
          "review_priority": "STANDARD",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "21",
          "submission_status": "AP",
          "submission_status_date": "20191115",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "60876",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/205692Orig1021, s024, s025ltr.pdf",
              "date": "20200323",
              "type": "Letter"
            },
            {
              "id": "60891",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205692s021s024s025lbl.pdf",
              "date": "20200323",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "BLA205692",
      "sponsor_name": "ELI LILLY AND CO",
      "openfda": {
        "application_number": [
          "BLA205692"
        ],
        "brand_name": [
          "BASAGLAR KWIKPEN",
          "BASAGLAR TEMPO PEN"
        ],
        "generic_name": [
          "INSULIN GLARGINE"
        ],
        "manufacturer_name": [
          "Eli Lilly and Company"
        ],
        "product_ndc": [
          "0002-7715",
          "0002-8214"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "INSULIN GLARGINE"
        ],
        "rxcui": [
          "847230",
          "1736863",
          "2268064",
          "2268065"
        ],
        "spl_id": [
          "3c2283e6-2844-44d2-a447-579b07e77c27"
        ],
        "spl_set_id": [
          "0ad21db3-2b1c-4ed9-a687-bdd6a74d0aae"
        ],
        "package_ndc": [
          "0002-7715-01",
          "0002-7715-59",
          "0002-7715-63",
          "0002-8214-01",
          "0002-8214-05"
        ],
        "nui": [
          "M0011417",
          "N0000175453"
        ],
        "pharm_class_cs": [
          "Insulin [CS]"
        ],
        "pharm_class_epc": [
          "Insulin Analog [EPC]"
        ],
        "unii": [
          "2ZM8CX04RZ"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "BASAGLAR",
          "active_ingredients": [
            {
              "name": "INSULIN GLARGINE",
              "strength": "300 UNITS/3ML (100 UNITS/ML)"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "SOLUTION",
          "route": "SUBCUTANEOUS",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}